Sagility Ltd
NSE: SAGILITY BSE: 544282Healthcare
Incorporated in July 2021, Sagility India Limited (formerly Berkmeer India Pvt. Ltd) provides healthcare-focused technology-enabled solutions and services primarily to U.S.-based clients in the payer and provider segments.[1]
₹41.5
52W: ₹35.8 — ₹57.9
PE 51.7 · Book ₹22.3 · +86% vs bookMarket Cap₹19,409 Cr
Stock P/E51.7Price to Earnings
ROCE5.03%Return on Capital
ROE3.65%Return on Equity
Div. Yield0.12%Face Value ₹10
Strengths
- +Company has reduced debt.
- +Company is almost debt free.
- +Debtor days have improved from 162 to 94.3 days.
Weaknesses
- −Company has a low return on equity of 2.87% over last 3 years.
Shareholding Pattern
Promoters50.95%
FIIs10.02%
DIIs22.28%
Public16.75%
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 82.39% | 82.39% | 67.38%▼15.0 | 67.38% | 50.95%▼16.4 | 50.95% |
| FIIs | 3.77% | 3.39%▼0.4 | 5.99%▲2.6 | 5.59%▼0.4 | 10.25%▲4.7 | 10.02%▼0.2 |
| DIIs | 7.25% | 7.47%▲0.2 | 14.07%▲6.6 | 14.87%▲0.8 | 21.36%▲6.5 | 22.28%▲0.9 |
| Public | 6.59% | 6.75%▲0.2 | 12.57%▲5.8 | 12.15%▼0.4 | 17.44%▲5.3 | 16.75%▼0.7 |
Financial Statements
| Metric | Sep 2023 | Dec 2023 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 366 | 370 | 387 | 421 | 454 | 455 | 473 | 492 | 505 | 502 |
| Expenses | 197 | 236 | 316 | 284 | 292 | 313 | 310 | 334 | 355 | 394 |
| Operating Profit | 169 | 134 | 71 | 137 | 162 | 142 | 163 | 158 | 150 | 108 |
| OPM % | 46% | 36% | 18% | 32% | 36% | 31% | 34% | 32% | 30% | 22% |
| Net Profit | -8 | 94 | 6 | 73 | 110 | 82 | 97 | 111 | 69 | 74 |
| EPS ₹ | -0.04 | 0.49 | 0.01 | 0.16 | 0.24 | 0.17 | 0.21 | 0.24 | 0.15 | 0.16 |
AI Insights
Revenue Trend
Mar 2026 revenue at ₹1,971Cr, up 14.8% YoY. OPM at 29%.
Debt Position
Borrowings at ₹787Cr. Debt-to-equity ratio: 0.14x. Healthy balance sheet.
Institutional Flow
DIIs: 22.28% (+15.03pp change). FIIs: 10.02% (+6.25pp change). Promoters hold 50.95%.
Margin & Efficiency
ROCE improving from 0% (Mar 2022) to 5% (Mar 2026). Working capital days: -7.
Valuation
PE 51.7x with 5.03% ROCE. Price is 86% above book value of ₹22.3. Dividend yield: 0.12%.
Recent Announcements
- Announcement under Regulation 30 (LODR)-Earnings Call Transcript 2d - Transcript of Earnings Call held on May 12, 2026
- Announcement under Regulation 30 (LODR)-Newspaper Publication 14 May - Newspaper publication of audited financial results for the quarter and year ended March 31, 2026
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 13 May - Investor webinar recording for audited Q4 and FY2026 results, held May 12, 2026, posted on website.
- Announcement under Regulation 30 (LODR)-Dividend Updates 12 May - Board recommended final dividend of Rs.0.10 per share for FY2025-26, subject to AGM approval.
- Proposal Of ''Employee Stock Options And Performance Stock Units Scheme 2026'' 12 May - Board approved ESOS 2026 with 3.09 crore options and 12.36 crore PSUs, subject to shareholder approval.
- Financial Year 2025 from bse
- Rating update 22 Jan from icra
- Rating update 5 Jan from crisil